Neuroinflammatory Disease following Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children
暂无分享,去创建一个
N. Boddaert | Shen-Ying Zhang | I. Desguerre | M. Hully | F. Rozenberg | R. Basmaci | M. Aubart | F. Moulin | Charles-Joris Roux | L. De Pontual | F. Angoulvant | M. Leruez-Ville | V. Gajdos | P. Blanc | C. Gitiaux | D. Sterlin | K. Yacouben | M. Robert | S. Wehbi | M. Kossorotoff | A. Debray | S. Rouget | Z. Belhadjer | C. Durrleman | C. Gins | E. Georget | M. Mazeghrane | Raphaël Levy | Temi Kom | Jérémie Tencer
[1] C. Bien,et al. MOG antibody-associated encephalitis secondary to Covid-19: case report , 2021, BMC Neurology.
[2] A. P. Antunes,et al. Longitudinally extensive transverse myelitis with anti-myelin oligodendrocyte glycoprotein antibodies following SARS-CoV-2 infection , 2021, Journal of Neuroimmunology.
[3] W. Vargas,et al. Postinfectious Encephalomyelitis Associated With Myelin Oligodendrocyte Glycoprotein Antibody in a Pediatric Patient With COVID-19. , 2021, Pediatric neurology.
[4] S. Gulati,et al. Acute Demyelinating Syndrome (MOG Antibody Positive) Associated With COVID-19 Infection: A Widening spectrum , 2021, Clinical pediatrics.
[5] L. Žorić,et al. Optic Neuritis in a Patient with Seropositive Myelin Oligodendrocyte Glycoprotein Antibody During the Post-COVID-19 Period , 2021, International medical case reports journal.
[6] D. Kariyawasam,et al. Prior infection by seasonal coronaviruses, as assessed by serology, does not prevent SARS-CoV-2 infection and disease in children, France, April to June 2020 , 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[7] S. Farhadian,et al. MOG-associated encephalitis following SARS-COV-2 infection , 2021, Multiple Sclerosis and Related Disorders.
[8] S. Gunzler,et al. COVID-19, HHV6 and MOG antibody: A perfect storm , 2021, Journal of Neuroimmunology.
[9] I. Kohane,et al. Multinational Prevalence of Neurological Phenotypes in Patients Hospitalized with COVID-19 , 2021, medRxiv.
[10] R. Khubchandani,et al. Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Disease in a 11 Year Old with COVID-19 Infection , 2021, Indian Journal of Pediatrics.
[11] W. Vargas,et al. Neurological issues in children with COVID-19 , 2020, Neuroscience Letters.
[12] P. Grant,et al. Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study , 2020, The Lancet Child & Adolescent Health.
[13] L. Henderson,et al. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 2 , 2020, Arthritis & rheumatology.
[14] M. Levin,et al. Multisystem Inflammatory Syndrome in Children: An International Survey , 2020, Pediatrics.
[15] K. Sawalha,et al. COVID-19-Induced Acute Bilateral Optic Neuritis , 2020, Journal of investigative medicine high impact case reports.
[16] R. Gons,et al. Neuromyelitis optica spectrum disorder after presumed coronavirus (COVID-19) infection: A case report , 2020, Multiple Sclerosis and Related Disorders.
[17] S. Farmer,et al. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome , 2020, medRxiv.
[18] Maria Thom,et al. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings , 2020, Brain : a journal of neurology.
[19] U. Löbel,et al. Neurologic and Radiographic Findings Associated With COVID-19 Infection in Children. , 2020, JAMA neurology.
[20] C. Azevedo,et al. Myelin Oligodendrocyte Glycoprotein Antibody–Associated Optic Neuritis and Myelitis in COVID-19 , 2020, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
[21] G. Carcelain,et al. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort , 2020, Annals of the Rheumatic Diseases.
[22] P. Frange,et al. Severe and fatal forms of COVID-19 in children , 2020, Archives de Pédiatrie.
[23] S. Kremer,et al. Neurologic Features in Severe SARS-CoV-2 Infection , 2020, The New England journal of medicine.
[24] L. Mao,et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. , 2020, JAMA neurology.
[25] C. Langenberg,et al. SARS-CoV-2 (COVID-19): What Do We Know About Children? A Systematic Review , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[26] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[27] D. Arnold,et al. Serial Anti–Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes , 2019, JAMA neurology.
[28] M. Buchmeier,et al. Exacerbated Pathology of Viral Encephalitis in Mice with Central Nervous System-Specific Autoantibodies , 2007, The American Journal of Pathology.
[29] I. Gresser,et al. Pronounced antiviral activity of human interferon on bovine and porcine cells , 1974, Nature.